French National Agency for Research on AIDS and Viral Hepatitis
anrs.frTotal trials
91
Active
0
Phase 3
36
Total enrollment
71,090
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- HIV Infections54
- HIV Infection13
- Tuberculosis8
- Hepatitis C, Chronic6
- Chronic Hepatitis C5
- AIDS4
- HIV-Associated Lipodystrophy Syndrome3
- Hepatitis C3
Frequently asked questions about French National Agency for Research on AIDS and Viral Hepatitis
- How many clinical trials does French National Agency for Research on AIDS and Viral Hepatitis have on ClinicalTrials.gov?
- French National Agency for Research on AIDS and Viral Hepatitis is listed as the lead sponsor on 91 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of French National Agency for Research on AIDS and Viral Hepatitis's trials are in Phase 3?
- 36 of French National Agency for Research on AIDS and Viral Hepatitis's trials are in Phase 3.
- What therapeutic areas does French National Agency for Research on AIDS and Viral Hepatitis focus on?
- French National Agency for Research on AIDS and Viral Hepatitis's most-studied conditions on ClinicalTrials.gov are HIV Infections, HIV Infection, Tuberculosis, Hepatitis C, Chronic, Chronic Hepatitis C.